Prange Pharma Completes Acquisition of MSD Animal Health Site in Italy

Business Strategy Prange Pharma Completes Acquisition of MSD Animal Health Site in Italy

2026-04-07 Source: Press release Prange Pharma 1 min Reading Time

Related Vendors

Lutz Pumpen GmbH

Maag Pump Systems AG

Italvacuum, Srl

Prange Pharma has successfully completed the acquisition of MSD Animal Health’s manufacturing site in Aprilia, Italy. The site will now operate under the new name Aprilia Animal Health.

Prange Pharma recently announced the successful completion of the acquisition of the MSD Animal Health manufacturing site in Aprilia, Italy. (Source: Pixabay) — Prange Pharma recently announced the successful completion of the acquisition of the MSD Animal Health manufacturing site in Aprilia, Italy.
(Source: Pixabay)

Aprilia/Italy – Prange Pharma recently announced the successful completion of the acquisition of the MSD Animal Health manufacturing site in Aprilia, Italy. Following closing, the site will operate under the new name Aprilia Animal Health, establishing a dedicated European platform for contract manufacturing in the animal health sector.

The transaction marks a key milestone in Prange Pharma’s strategy to expand its footprint in Europe and strengthen its capabilities in animal health manufacturing. With its broad technological setup, including sterile and non-sterile production as well as specialized product categories, Aprilia Animal Health is positioned as a centre of excellence for global customers.

At the same time, Prange Pharma and MSD Animal Health are entering a long-term supply partnership, ensuring continuity for existing products and a seamless transition for customers.

Stay up to Date

Do you want the latest news, specialist articles and information on new products? Then you can register for our free newsletter:

Choose your Newsletter

With more than 65 years of manufacturing experience and a highly skilled workforce, the Aprilia site will continue to play a critical role in the supply of veterinary pharmaceuticals, while opening new opportunities for third-party CDMO business.

Otto Prange, Owner of Prange Group, commented: “This successful closing represents an important step in executing our long-term growth strategy. Aprilia Animal Health will become a key pillar of our European manufacturing network.”

Sebastian Heckerodt, Managing Director of Prange Pharma, added: “We are proud to officially welcome the Aprilia team to Prange Pharma. Our focus is now on integration, further investment and developing Aprilia Animal Health into a leading CDMO partner for the global animal health industry.”

(ID:50807555)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Date: 08.12.2025

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.